VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025

Core Viewpoint - Virbac has appointed Paul Martingell as the new CEO, effective September 1, 2025, bringing extensive international experience in consumer health and pharmaceuticals to the role [1][5]. Group 1: Leadership and Experience - Paul Martingell, aged 45, has over 25 years of international experience, particularly in consumer health, consumer goods, and pharmaceuticals [1][2]. - His previous roles include significant positions at Ernst & Young, Reckitt Benckiser, and Novartis Consumer Healthcare, where he was part of the executive committee overseeing the merger of Boehringer Ingelheim's and Sanofi's Consumer Healthcare businesses [2][3]. - Martingell has demonstrated leadership in developing diverse teams and leading successful transformations, focusing on growth and performance [3]. Group 2: Strategic Vision - Martingell expressed enthusiasm for joining Virbac and aims to innovate and create a lasting impact in the animal health sector [4]. - The board of directors believes that his background and leadership style will contribute to the long-term development of Virbac by providing a new perspective [5]. Group 3: Transition and Acknowledgment - The board of directors acknowledged the contributions of Habib Ramdani, who served as interim CEO prior to Martingell's appointment [6].